Nuclear Stock Face-Off: Is Oklo or Cameco the Better Buy Right Now?

Cameco is highlighted as the better buy, backed by its position as North America's largest uranium supplier, a $2.6 billion long-term uranium supply deal with India, and a 49% stake in Westinghouse tied to an $80 billion U.S. reactor construction partnership. Oklo is progressing its advanced Aurora Powerhouse reactor through the DOE pilot program, with first deployment targeted for late 2027 or early 2028 and a 1.2 GW campus for Meta expected in 2030. The article is broadly constructive on nuclear power demand from AI data centers, but the investment conclusion favors the more established Cameco over the higher-risk, early-stage Oklo.

Analysis

The market is starting to price nuclear less as a utility-equity story and more as a data-center infrastructure bottleneck trade. That matters because the real winner is not just the miner or the reactor developer, but the firms that can convert regulatory optionality into contracted megawatts: fuel supply, project finance, and long-duration service cash flows. In that framing, CCJ has the cleaner earnings path because uranium scarcity and Western supply-chain de-risking can re-rate both commodity and downstream service economics before a single new reactor comes online.

OKLO is the higher-beta call option on regulatory acceleration, but the setup remains structurally asymmetric to the downside near term. Its valuation is being pulled forward by AI power demand while its cash burn and execution risk are still anchored to a multi-year buildout, so the stock can outperform on headlines and underperform on any delay in licensing, site readiness, or cost inflation. The second-order winner from this theme may be BEP-style infrastructure capital: if governments and hyperscalers want speed, they will increasingly pay for balance-sheet capacity and permitting expertise rather than pure technology novelty.

Consensus is probably underestimating how slow nuclear expansion is relative to AI demand growth. That means near-term beneficiaries are likely to be fuel suppliers and existing nuclear ecosystem owners, not first-generation advanced-reactor names. The biggest reversal risk is policy: a single licensing setback, project overrun, or change in federal support could compress OKLO multiple quickly, while CCJ’s downside is more commodity-driven and therefore slower moving.

Key Decisions for Investors

• Long CCJ vs short OKLO as a 3- to 6-month relative-value trade: favor the name with near-term cash flow and downside support over the pre-revenue developer; target a 15-25% spread move if licensing optimism fades.
• Add CCJ on pullbacks for a 6-12 month horizon: use it as the cleaner expression of the nuclear buildout theme with lower execution risk and better linkage to fuel scarcity; risk/reward improves if uranium prices remain firm.
• Sell covered calls on OKLO into strength over the next 1-2 quarters: monetize implied volatility while limiting exposure to headline-driven multiple expansion; best when the stock rallies on policy/newsflow rather than contracts.
• Pair long BEP / short OKLO for a 6-9 month infrastructure-vs-speculation expression: if capital markets prefer contracted cash flows over venture-style execution risk, BEP should outperform in a risk-off tape.
• Set a tactical alert for any DOE/NRC delay or project slippage in OKLO: that is the fastest catalyst for a 20%+ air pocket, while positive approvals are likely to be faded unless accompanied by commercial contract wins.